Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
USPSTF has released draft recommendations on aspirin to prevent colon cancer and cardiovascular disease
The U.S. Preventive Services Task Force (USPSTF) has published a draft recommendation for the use of aspirin to prevent cardiovascular disease and cancer.
According to the Task Force, taking aspirin can help prevent colorectal cancer, but should only be taken in low doses by certain people.
Only those who are not at increased risk of bleeding and have at least a 10 year life expectancy should take low-dose aspirin every day, according to the draft recommendation which is open to public comment until October.
The draft proposal added that this advice only applies to those between 50 and 70 years of age. "Taking aspirin is easy, but deciding whether or not to take aspirin for prevention is complex," says Task Force vice chair Kirsten Bibbins-Domingo, MD.
"People aged 50 to 69 should talk with their doctor about their risk of cardiovascular disease and risk of bleeding, and discuss whether taking aspirin is right for them."
Source: U.S. Preventive Services Task Force
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.